Last reviewed · How we verify

NCT06849375

Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation

Recruiting now NA Last updated 27 February 2025
What this trial tests

NA trial testing phakic IOL implantation in Corneal Endothelial Cells in 30 participants. Currently enrolling.

Timeline
10 May 2024
Primary endpoint
20 December 2025
20 December 2025

Quick facts

Lead sponsorSohag University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment30
Start date10 May 2024
Primary completion20 December 2025
Estimated completion20 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 18 to 35, any sex, with Corneal Endothelial Cells. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

our primary aim of the work to assess the effect of phakic IOL implantation on corneal endothelium. we also used the specular microscope to assess the corneal endothelium

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06849375.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing